Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNanobiotix Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q2 2026 | 1 | $0.05 | $0.05 | $0.05 |
| Q1 2027 | 1 | $0.09 | $0.09 | $0.09 |
| Q2 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
Nanobiotix Earnings Date And Information
Nanobiotix last posted its earnings results on Tuesday, September 29th, 2026. The company reported $-0.7981 earnings per share for the quarter, missing analysts' consensus estimates of $-0.48457 by $0.31353. The company had revenue of 5.55 M for the quarter and had revenue of 29.64 M for the year. Nanobiotix has generated $-1 earnings per share over the last year ($-0.5 diluted earnings per share) and currently has a price-to-earnings ratio of -24.8. Nanobiotix has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Nanobiotix Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/24/2026 | Q2 2026 | N/A | -$0.71 | N/A | $1.51 M | $5.55 M |
| 03/31/2026 | Q4 2025 | $0.30 | -$0.39 | -0.69 | $43.71 M | $3.01 M |
| 09/30/2025 | Q2 2025 | -$0.25 | -$0.11 | 0.14 | $20.40 M | $26.64 M |
| 04/02/2025 | Q4 2024 | -$0.62 | -$0.98 | -0.36 | N/A | $-16,479,000 |
| 09/18/2024 | Q2 2024 | N/A | -$0.46 | N/A | $23.27 M | $9.29 M |
| 04/24/2024 | Q4 2023 | -$0.83 | -$0.30 | 0.53 | N/A | $32.92 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.80 | N/A | N/A | $3.29 M |
| 04/24/2023 | Q4 2022 | N/A | -$0.88 | N/A | N/A | $3.45 M |
| 09/28/2022 | Q2 2022 | N/A | -$0.76 | N/A | N/A | $1.33 M |
| 04/08/2022 | Q4 2021 | N/A | -$0.48 | N/A | N/A | $1.33 M |
| 09/08/2021 | Q2 2021 | -$0.60 | -$0.88 | -0.28 | N/A | $1.32 M |
| 04/07/2021 | Q4 2020 | N/A | -$0.47 | N/A | N/A | $877.00 K |
| 06/30/2020 | Q2 2020 | N/A | -$0.91 | N/A | N/A | $1.45 M |
| 12/31/2019 | Q4 2019 | N/A | -$1.21 | N/A | N/A | $718.00 K |
| 06/30/2019 | Q2 2019 | N/A | -$1.15 | N/A | N/A | $1.82 M |
| 12/31/2018 | Q4 2018 | N/A | -$0.92 | N/A | N/A | $1.42 M |
| 06/30/2018 | Q2 2018 | N/A | -$0.64 | N/A | N/A | $2.06 M |
| 12/31/2017 | Q4 2017 | N/A | -$0.74 | N/A | N/A | $1.84 M |
| 06/30/2017 | Q2 2017 | N/A | -$0.76 | N/A | N/A | $1.88 M |
| 12/31/2016 | Q4 2016 | N/A | -$0.76 | N/A | N/A | $2.39 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nanobiotix Earnings: FAQ's
The conference call for Nanobiotix's latest earnings report can be listened to online.
The conference call transcript for Nanobiotix's latest earnings report can be read online.
Nanobiotix (:NBTX) has a recorded annual revenue of $29.64 M.
Nanobiotix (:NBTX) has a recorded net income of $-23,961,000.Nanobiotix has generated $-0.5 earnings per share over the last four quarters.
Nanobiotix (:NBTX) has a price-to-earnings ratio of -24.8 and price/earnings-to-growth ratio is 0.2.